JP2024527340A5 - - Google Patents
Info
- Publication number
- JP2024527340A5 JP2024527340A5 JP2023581043A JP2023581043A JP2024527340A5 JP 2024527340 A5 JP2024527340 A5 JP 2024527340A5 JP 2023581043 A JP2023581043 A JP 2023581043A JP 2023581043 A JP2023581043 A JP 2023581043A JP 2024527340 A5 JP2024527340 A5 JP 2024527340A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- present
- amount ranging
- casein
- chitosan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163202970P | 2021-07-01 | 2021-07-01 | |
| US63/202,970 | 2021-07-01 | ||
| PCT/US2022/035870 WO2023278802A1 (en) | 2021-07-01 | 2022-06-30 | Formulations for oral delivery of nucleic acids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527340A JP2024527340A (ja) | 2024-07-24 |
| JP2024527340A5 true JP2024527340A5 (https=) | 2025-07-07 |
Family
ID=84690648
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023581003A Pending JP2024525512A (ja) | 2021-07-01 | 2022-06-30 | 治療用核酸及びその使用方法 |
| JP2023581043A Pending JP2024527340A (ja) | 2021-07-01 | 2022-06-30 | 核酸の経口送達用の製剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023581003A Pending JP2024525512A (ja) | 2021-07-01 | 2022-06-30 | 治療用核酸及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20250025487A1 (https=) |
| EP (2) | EP4363434A4 (https=) |
| JP (2) | JP2024525512A (https=) |
| KR (2) | KR20240028486A (https=) |
| CN (2) | CN117916249A (https=) |
| AU (2) | AU2022303384A1 (https=) |
| CA (2) | CA3223495A1 (https=) |
| WO (2) | WO2023278802A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3563859B1 (en) | 2012-08-13 | 2021-10-13 | Cedars-Sinai Medical Center | Cardiosphere-derived exosomes for tissue regeneration |
| EP4494699A3 (en) | 2014-10-03 | 2025-04-30 | Cedars-Sinai Medical Center | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy |
| EP3749344A4 (en) | 2018-02-05 | 2022-01-26 | Cedars-Sinai Medical Center | METHODS OF THERAPEUTIC USE OF EXOSOMES AND Y-RNAS |
| JP2025534332A (ja) * | 2022-09-30 | 2025-10-15 | セダーズ－シナイ メディカル センター | 治療用核酸及びその使用方法 |
| AU2024340578A1 (en) * | 2023-09-15 | 2026-03-05 | Cedars-Sinai Medical Center | Trex-1 augmentation to attenuate genotoxic stress and exert cardioprotection |
| WO2026035744A1 (en) | 2024-08-08 | 2026-02-12 | Cedars-Sinai Medical Center | Combination therapies for metabolic disease |
| WO2026035943A1 (en) * | 2024-08-08 | 2026-02-12 | Cedars-Sinai Medical Center | Formulations for oral delivery of nucleic acids |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7780873B2 (en) * | 2004-02-23 | 2010-08-24 | Texas A&M University System | Bioactive complexes compositions and methods of use thereof |
| US20120301463A1 (en) * | 2009-09-30 | 2012-11-29 | President And Fellows Of Harvard College | Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products |
| WO2014152211A1 (en) * | 2013-03-14 | 2014-09-25 | Moderna Therapeutics, Inc. | Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions |
| ES2724549T3 (es) * | 2013-10-18 | 2019-09-12 | Inst Nat Sante Rech Med | ARN pequeños derivados de RNY como biomarcadores para trastornos relacionados con la aterosclerosis |
| EP3247716A4 (en) * | 2015-01-20 | 2018-10-17 | Miragen Therapeutics, Inc. | Mir-92 inhibitors and uses thereof |
| US20190365913A1 (en) * | 2016-02-04 | 2019-12-05 | Tarveda Therapeutics, Inc. | Stapled peptide conjugates and particles |
| US11859234B2 (en) * | 2016-05-06 | 2024-01-02 | The Trustees Of Princeton University | Method of monitoring RNase L activity |
| US12258594B2 (en) * | 2018-12-05 | 2025-03-25 | The Broad Institute, Inc. | Cas proteins with reduced immunogenicity and methods of screening thereof |
| WO2020131986A1 (en) * | 2018-12-21 | 2020-06-25 | Pioneer Hi-Bred International, Inc. | Multiplex genome targeting |
-
2022
- 2022-06-30 WO PCT/US2022/035870 patent/WO2023278802A1/en not_active Ceased
- 2022-06-30 JP JP2023581003A patent/JP2024525512A/ja active Pending
- 2022-06-30 CN CN202280059708.7A patent/CN117916249A/zh active Pending
- 2022-06-30 KR KR1020247003755A patent/KR20240028486A/ko active Pending
- 2022-06-30 US US18/571,924 patent/US20250025487A1/en active Pending
- 2022-06-30 CA CA3223495A patent/CA3223495A1/en active Pending
- 2022-06-30 EP EP22834283.8A patent/EP4363434A4/en active Pending
- 2022-06-30 CA CA3223686A patent/CA3223686A1/en active Pending
- 2022-06-30 EP EP22834280.4A patent/EP4362954A1/en active Pending
- 2022-06-30 US US18/572,067 patent/US20240285668A1/en active Pending
- 2022-06-30 JP JP2023581043A patent/JP2024527340A/ja active Pending
- 2022-06-30 AU AU2022303384A patent/AU2022303384A1/en active Pending
- 2022-06-30 AU AU2022303330A patent/AU2022303330A1/en active Pending
- 2022-06-30 WO PCT/US2022/035866 patent/WO2023278799A1/en not_active Ceased
- 2022-06-30 CN CN202280059718.0A patent/CN117897162A/zh active Pending
- 2022-06-30 KR KR1020247003744A patent/KR20240027814A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024527340A5 (https=) | ||
| JP2023138984A (ja) | Ｖｅｇｆ－ａポリペプチドをコードする改変ｒｎａを送達するための脂質ナノ粒子 | |
| DE60219611T2 (de) | Modifizierte annexin-proteine und verhinderung und behandlung von thrombose | |
| US20160250290A1 (en) | Gene therapy for diabetic ischemic disease | |
| CN113993526B (zh) | 包含源自牛奶的外泌体作为有效成分的用于治疗代谢性疾病的药物组合物 | |
| US20240285668A1 (en) | Formulations for oral delivery of nucleic acids | |
| JP2024525512A5 (https=) | ||
| WO1997044056A1 (en) | Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma | |
| CN119584980A (zh) | 使用mazdutide的治疗方法 | |
| Hemachudha et al. | Letter to the Editor Paralytic complications following intravenous rabies immune globulin treatment in a patient with furious rabies | |
| US20220226243A1 (en) | Methods of using lipid nanoparticles for delivering modified rna encoding a vegf-a polypeptide and pharmaceutical compositions comprising the same | |
| AU747885B2 (en) | Treatment of disease states | |
| EP4041281B1 (en) | Use of gdf15 for treating cardiometabolic syndrome and other conditions | |
| RU2032422C1 (ru) | Способ лечения инфаркта миокарда | |
| JP2021167354A (ja) | 薬物動態及び／又は安全性に優れるテリパラチド含有液状医薬組成物 | |
| CN103013902B (zh) | 产降钙素基因相关肽与犬钩虫抗凝肽AcAP5融合蛋白基因工程菌株及其构建方法 | |
| TWI309570B (https=) | ||
| Lee et al. | Chronic mucocutaneous candidiasis with candida granuloma treated with 5-fluorocytosine | |
| CN120248021A (zh) | 一种鳖甲寡肽i-c-f-6产品及其在制备药物中的应用 | |
| WO2025208818A1 (zh) | 治疗下肢外周动脉疾病的核酸分子、药物组合物及其应用 | |
| JP2023538984A5 (https=) | ||
| JP2025512987A5 (https=) | ||
| CN110898080A (zh) | 鲎血浆在促生长发育中的应用 | |
| Takakura¹ et al. | 68. Effect of interferons and an interferon inducer on malignant brain tumors | |
| JP2000169394A (ja) | アポトーシス誘導剤 |